Nemolizumab monotherapy is effective and well-tolerated among adults with moderate to severe prurigo nodularis through 100 weeks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results